Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $585.67 | 33 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Kowa Pharmaceuticals America, Inc. | $163.44 | 10 | $0 (2023) |
| Upsher-Smith Laboratories LLC | $58.74 | 2 | $0 (2020) |
| Novo Nordisk Inc | $48.29 | 3 | $0 (2021) |
| Amgen Inc. | $43.40 | 3 | $0 (2021) |
| Supernus Pharmaceuticals, Inc. | $38.33 | 2 | $0 (2023) |
| AbbVie Inc. | $37.14 | 2 | $0 (2021) |
| Amarin Pharma Inc. | $36.38 | 2 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $33.50 | 2 | $0 (2019) |
| Medtronic Vascular, Inc. | $29.86 | 1 | $0 (2019) |
| Hikma Pharmaceuticals USA | $23.88 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $65.68 | 4 | Supernus Pharmaceuticals, Inc. ($38.33) |
| 2021 | $79.66 | 5 | Kowa Pharmaceuticals America, Inc. ($32.91) |
| 2020 | $213.21 | 11 | Kowa Pharmaceuticals America, Inc. ($103.18) |
| 2019 | $85.68 | 4 | Medtronic Vascular, Inc. ($29.86) |
| 2018 | $79.48 | 5 | Amgen Inc. ($31.55) |
| 2017 | $61.96 | 4 | Janssen Pharmaceuticals, Inc ($19.93) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/17/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: PAIN MANAGEMENT | ||||||
| 07/05/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/22/2023 | Supernus Pharmaceuticals, Inc. | XYOSTED (Drug), TLANDO | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 06/15/2023 | Supernus Pharmaceuticals, Inc. | TLANDO (Drug), XYOSTED | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/10/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $15.47 | General |
| Category: Cardiovascular | ||||||
| 08/17/2021 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: Inflammation | ||||||
| 07/22/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Diabetes | ||||||
| 04/07/2021 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: IMMUNOLOGY | ||||||
| 02/03/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $17.44 | General |
| Category: Cardiovascular | ||||||
| 12/10/2020 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $17.44 | General |
| Category: Cardiovascular | ||||||
| 10/13/2020 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $15.37 | General |
| Category: Cardiovascular | ||||||
| 10/05/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Diabetes | ||||||
| 09/02/2020 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $16.63 | General |
| Category: Cardiovascular | ||||||
| 08/05/2020 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: NEUROSCIENCE | ||||||
| 07/28/2020 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $18.29 | General |
| Category: Cardiovascular | ||||||
| 07/20/2020 | Upsher-Smith Laboratories LLC | TOSYMRA SUMATRIPTAN NASAL SPRAY (Drug), ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION | Food and Beverage | In-kind items and services | $32.98 | General |
| Category: NEUROLOGY | ||||||
| 07/15/2020 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $17.70 | General |
| Category: Cardiovascular | ||||||
| 06/23/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Cardiovascular | ||||||
| 06/15/2020 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $17.75 | General |
| Category: Cardiovascular | ||||||
| 04/24/2020 | Upsher-Smith Laboratories LLC | TOSYMRA SUMATRIPTAN NASAL SPRAY (Drug), ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION, TOPIRAMATE EXTENDED RELEASE CAPSULES | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: NEUROLOGY | ||||||
| 11/18/2019 | ALK-Abello, Inc | Odactra (Drug), Grastek, Ragwitek | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Allergy and Immunology | ||||||
| 10/08/2019 | Hikma Pharmaceuticals USA | Mitigare (Drug) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/20/2019 | Medtronic Vascular, Inc. | VenaSeal (Device) | Food and Beverage | In-kind items and services | $29.86 | General |
| Category: EndoVenous Therapies | ||||||
| 04/08/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/28/2018 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 302 | 552 | $82,820 | $39,859 |
| 2022 | 4 | 204 | 389 | $57,094 | $23,020 |
| 2021 | 9 | 540 | 831 | $83,491 | $37,660 |
| 2020 | 3 | 86 | 170 | $31,856 | $12,038 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 300 | $55,510 | $22,917 | 41.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 71 | 71 | $10,295 | $8,744 | 84.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 79 | $11,850 | $4,318 | 36.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 65 | 71 | $3,855 | $3,077 | 79.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 18 | 20 | $848.00 | $577.40 | 68.1% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 11 | 11 | $462.00 | $225.06 | 48.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 92 | 249 | $44,431 | $18,262 | 41.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 71 | $9,760 | $3,200 | 32.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 33 | 34 | $1,428 | $924.88 | 64.8% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 35 | 35 | $1,475 | $632.19 | 42.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 80 | 173 | $32,005 | $15,335 | 47.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 61 | 106 | $15,900 | $6,600 | 41.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 49 | $11,123 | $5,937 | 53.4% |
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2021 | 220 | 326 | $15,930 | $5,676 | 35.6% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 75 | 75 | $3,750 | $2,771 | 73.9% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 25 | 25 | $1,225 | $513.25 | 41.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 29 | 29 | $1,218 | $456.46 | 37.5% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 17 | 20 | $1,060 | $203.76 | 19.2% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 22 | 28 | $1,280 | $167.38 | 13.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 11 | 48 | $10,896 | $4,959 | 45.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 39 | 76 | $14,060 | $4,832 | 34.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 36 | 46 | $6,900 | $2,248 | 32.6% |
About Dr. James Lee, DO
Dr. James Lee, DO is a Family Medicine healthcare provider based in Brunswick, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1033118880.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Lee, DO has received a total of $585.67 in payments from pharmaceutical and medical device companies, with $65.68 received in 2023. These payments were reported across 33 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($585.67).
As a Medicare-enrolled provider, Lee has provided services to 1,132 Medicare beneficiaries, totaling 1,942 services with total Medicare billing of $112,578. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Brunswick, GA
- Active Since 07/14/2005
- Last Updated 06/27/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1033118880
Products in Payments
- Livalo (Drug) $136.09
- TOSYMRA SUMATRIPTAN NASAL SPRAY (Drug) $58.74
- Vascepa (Drug) $36.38
- XARELTO (Drug) $33.50
- Ozempic (Drug) $31.95
- Aimovig (Biological) $31.55
- VenaSeal (Device) $29.86
- SEGLENTIS (Drug) $27.35
- Mitigare (Drug) $23.88
- SYNTHROID (Drug) $21.03
- XYOSTED (Drug) $19.74
- TLANDO (Drug) $18.59
- Odactra (Drug) $18.37
- Victoza (Drug) $16.34
- Androgel (Drug) $16.11
- ANORO (Drug) $15.48
- TRINTELLIX (Drug) $14.20
- CONTRAVE (Drug) $14.09
- Otezla (Drug) $11.85
- Trulance (Drug) $10.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Brunswick
James Fleming, M.d, M.D
Family Medicine — Payments: $6,870
Michael Macdonald, Md, MD
Family Medicine — Payments: $5,525
Leonard Kinland, M.d, M.D
Family Medicine — Payments: $5,252
Dr. John Blumer, M.d, M.D
Family Medicine — Payments: $4,731
Mark Meacham, Md, MD
Family Medicine — Payments: $3,673
Jelisa Carroll
Family Medicine — Payments: $3,544